Hematology Market is likely to witness an impressive CAGR of 5.5% during the forecast period. Growing incidences of blood disorders and other diseases, increasing importance of hematological testing in COVID-19 infected patients, rapid technological advancements in hematology, and the emergence of high throughput hematology analyzers are some of the major factors expected to drive the growth of the market during the forecast period.